Volume 175 Issue 9

Editorials

• Are the new Lipid Management Guidelines good for Australia's health? Rodney T Jackson (MJA 2001; 175: 452-453)
• Chronic pain in children John J Collins, Lynette J Lane, Susan Thompson (MJA 2001; 175: 453-454)
• Acute myocardial infarction: improving quality of care Richmond W Jeremy (MJA 2001; 175: 454-455)
• Breaking the back of back pain Rachelle Buchbinder, Damien Jolley, Mary Wyatt (MJA 2001; 175: 456-457)

Research

• Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria Stephen S Lim, Theo Vos, Anna Peeters, Danny Liew, John J McNeil (MJA 2001; 175: 459-464)
• The effects of quality improvement interventions on inhospital mortality after acute myocardial infarction Ian A Scott, Michael D Coory, Catherine M Harper (MJA 2001; 175: 465-470)
• Lipid lowering and coronary heart disease risk: how appropriate are the national guidelines? Brett H Forge, Esther M Briganti (MJA 2001; 175: 471-475)

Healthcare

• Management of chronic pain in children George A Chalkiadis (MJA 2001; 175: 476-479)

Notable Cases

• Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin Peter B Ward, Paul D R Johnson, Elizabeth A Grabsch, Barrie C Mayall, M Lindsay Grayson (MJA 2001; 175: 480-483)
• Meningitis and septicaemia in a child caused by non-typable Haemophilus influenzae biotype III Stephen E Kay, Zoltan Nack, Bernard M Jenner (MJA 2001; 175: 484-485)

Clinical Update

• Statin-associated myopathy Ian Hamilton-Craig (MJA 2001; 175: 486-489)

EBM: Trials on Trial

• Selecting participants for clinical trials Anthony C Keech, Val J Gebski (MJA 2001; 175: 490-491)
• Is aggressive lipid-lowering therapy preferable to angioplasty in stable coronary artery disease? Peter M Ellis (MJA 2001; 175: 492-493)

Diagnostic Dilemmas

• Role of breast magnetic resonance imaging in difficult diagnostic situations Kerry E McMahon, Dennis R Osborne, Anne L Davidson (MJA 2001; 175: 494-497)